Statins × adverse events & safety

SynthesisThe Cochrane database of systematic reviews2020

Cerivastatin for lowering lipids.

Stephen P Adams et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 12,877 people · 2020

Range includes no effect

No clear effect on adverse events & safety

+9%−32% to +74%

Bigger than 3 in 10 for adverse events & safety

As reported

RR 1.09, 95% CI 0.68–1.74

One number in the abstract

the abstract, start to end

of these short-term trials (risk ratio 1.09, 95% confidence interval 0.68

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
RR 1.090.68–1.74
StatinsAdverse events & safety

Statins × adverse events & safetyharms?mixed

unlikelylikely
0.16not counted
← favours comparatorfavours treatment →
more certainless certain
1 / 5

14 papers cite it

2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31981471